Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý
Also in the Knowledge Center
Scientific Article
/ Jan 01, 2006
Process for the preparation of tamsulosin and intermediates thereof starting from chiral phenylethylamine and using catalytic hydrogenation as the key step
Read more
Scientific Article
/ Jan 01, 2006
Process for preparation of fluticasone analogs via esterification of a carbothioic acid
Read more
Scientific Article